Proteolytic Opening of the Blood-Brain Barrier During Neuroinflammation

  • Gary A. Rosenberg
  • Diedre Hofinger
  • Edward Y. Estrada
  • James A. Wallace
Part of the Keio University Symposia for Life Science and Medicine book series (KEIO, volume 6)

Summary

Matrix metalloproteinases (MMPs) have been shown to produce proteolytic opening of the blood-brain barrier (BBB) during a neuroinflammatory response. Cerebral ischemia with reperfusion causes a biphasic opening of the BBB that is associated with increases in the MMPs. We used immunohistochemistry to determine the cellular location of the MMPs in ischemic brain tissue after reperfusion. Adult Wistar-Kyoto rats (WKY) underwent a middle cerebral artery occlusion (MCAO) with the suture method. Brain uptake of radiolabeled sucrose was used to study the time course of the BBB opening. Zymograms were used to measure the type IV collagenases or gelatinases. Immunostaining was done with antibodies to gelatinase A (MMP-2), gelatinase B (MMP-9), and stromelysin (MMP-3). We found a biphasic opening of the BBB with a transient opening after 3h of reperfusion and a more extensive injury at 48 h. MMP-2 was associated with the initial opening and MMP-9 with the later one.

Immunohistochemistry of normal brain showed MMP-2 in the astrocytic end-feet abutting blood vessels. MMP-9 was mainly in endothelial cells in the ischemic region, whereas MMP-3 was in the perivascular cells. MMPs are important for reperfusion injury and contribute to the brain edema and intracerebral hemorrhage.

Key words

Blood-brain barrier Brain edema Cerebral ischemia Matrix metalloproteinases Reperfusion injury 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Birkedal-Hansen H (1995) Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728–735PubMedCrossRefGoogle Scholar
  2. 2.
    Mun-Bryce S, Rosenberg GA (1998) Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol 274:R1203–R1211PubMedGoogle Scholar
  3. 3.
    Kuroiwa T, Ting P, Martinez H, Klatzo I (1985) The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion. Acta Neuropathol (Berl) 68:122–129CrossRefGoogle Scholar
  4. 4.
    Rosenberg GA, Navratil M, Barone F, Feuerstein G (1996) Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 16:360–366PubMedCrossRefGoogle Scholar
  5. 5.
    Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29:1020–1030PubMedCrossRefGoogle Scholar
  6. 6.
    Rosenberg GA, Estrada EY, Dencoff JE (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29:2189–2195PubMedCrossRefGoogle Scholar
  7. 7.
    Heo JH, Lucero J, Abumiya T, Koziol JA, Copeland BR, del Zoppo GJ (1999) Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 19:624–633PubMedCrossRefGoogle Scholar
  8. 8.
    Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67–68PubMedCrossRefGoogle Scholar
  9. 9.
    Rosenberg GA, Kornfeld M, Estrada E, Kelley RO, Liotta LA, Stetler-Stevenson WG (1992) TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collage-nase. Brain Res 576:203–207PubMedCrossRefGoogle Scholar
  10. 10.
    Clark AW, Krekoski CA, Bou S-S, Chapman KR, Edwards DR (1997) Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 238:53–56PubMedCrossRefGoogle Scholar
  11. 11.
    Yong VW, Kerkoski CA, Forsyth PA, Bell R, Edwards DR (1998) Matrix metalloproteinases and diseases of the CNS. TINS 21:75–80PubMedGoogle Scholar
  12. 12.
    Mun-Bryce S, Rosenberg GA (1998) Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab 18:1163–1172PubMedCrossRefGoogle Scholar
  13. 13.
    Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84–91PubMedCrossRefGoogle Scholar
  14. 14.
    Nagase H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151–160PubMedGoogle Scholar
  15. 15.
    Mazzieri R, Masiero L, Zanetta L, et al (1997) Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J 16:2319–2332PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2001

Authors and Affiliations

  • Gary A. Rosenberg
    • 1
    • 2
  • Diedre Hofinger
    • 1
  • Edward Y. Estrada
    • 1
  • James A. Wallace
    • 2
  1. 1.Department of NeurologyUniversity of New MexicoAlbuquerqueUSA
  2. 2.Department of NeuroscienceUniversity of New MexicoAlbuquerqueUSA

Personalised recommendations